Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.16028834 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.16028834 |
3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.15642620 |
4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.93150496 |
5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.60327816 |
6 | detection of bacterium (GO:0016045) | 4.28017848 |
7 | detection of external biotic stimulus (GO:0098581) | 3.93947453 |
8 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.84670179 |
9 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.77536643 |
10 | negative regulation of T cell mediated immunity (GO:0002710) | 3.71102964 |
11 | * response to type I interferon (GO:0034340) | 3.67638246 |
12 | positive regulation of interferon-alpha production (GO:0032727) | 3.67602434 |
13 | * type I interferon signaling pathway (GO:0060337) | 3.63690093 |
14 | * cellular response to type I interferon (GO:0071357) | 3.63690093 |
15 | microglial cell activation (GO:0001774) | 3.58514966 |
16 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.57025540 |
17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.51921696 |
18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.51921696 |
19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.51921696 |
20 | modulation by symbiont of host immune response (GO:0052553) | 3.51921696 |
21 | positive regulation by symbiont of host defense response (GO:0052509) | 3.51921696 |
22 | modulation by symbiont of host defense response (GO:0052031) | 3.51921696 |
23 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.51414586 |
24 | regulation of interferon-alpha production (GO:0032647) | 3.50469340 |
25 | regulation of T cell tolerance induction (GO:0002664) | 3.48872651 |
26 | neutrophil activation involved in immune response (GO:0002283) | 3.43130439 |
27 | detection of biotic stimulus (GO:0009595) | 3.39798283 |
28 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.39545373 |
29 | immunoglobulin mediated immune response (GO:0016064) | 3.38020276 |
30 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.37391814 |
31 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.36908120 |
32 | regulation of tolerance induction (GO:0002643) | 3.36338291 |
33 | regulation of gamma-delta T cell activation (GO:0046643) | 3.34922547 |
34 | positive regulation of B cell differentiation (GO:0045579) | 3.29345586 |
35 | macrophage activation (GO:0042116) | 3.22793491 |
36 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.20489414 |
37 | response to host (GO:0075136) | 3.19233855 |
38 | response to host defenses (GO:0052200) | 3.19233855 |
39 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.19233855 |
40 | positive regulation of antigen processing and presentation (GO:0002579) | 3.16160590 |
41 | regulation of regulatory T cell differentiation (GO:0045589) | 3.13903622 |
42 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.13056550 |
43 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.12362047 |
44 | leukocyte aggregation (GO:0070486) | 3.12252729 |
45 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.07180264 |
46 | positive regulation of type 2 immune response (GO:0002830) | 3.06875653 |
47 | T cell migration (GO:0072678) | 3.06314870 |
48 | respiratory burst (GO:0045730) | 3.04386632 |
49 | positive regulation of tolerance induction (GO:0002645) | 3.04126208 |
50 | cellular extravasation (GO:0045123) | 3.03702121 |
51 | regulation of B cell differentiation (GO:0045577) | 3.02789658 |
52 | B cell receptor signaling pathway (GO:0050853) | 3.02073162 |
53 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.01095312 |
54 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 3.00375180 |
55 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.99356744 |
56 | tolerance induction (GO:0002507) | 2.99218160 |
57 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.94078340 |
58 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.92696555 |
59 | response to peptidoglycan (GO:0032494) | 2.92312216 |
60 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.92295553 |
61 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.92295553 |
62 | negative regulation of innate immune response (GO:0045824) | 2.90274951 |
63 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.89657282 |
64 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.89625602 |
65 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.88713367 |
66 | macrophage activation involved in immune response (GO:0002281) | 2.87173842 |
67 | neutrophil activation (GO:0042119) | 2.87117668 |
68 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.86747838 |
69 | dendritic cell chemotaxis (GO:0002407) | 2.86698784 |
70 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.86351550 |
71 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.86351550 |
72 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.84881984 |
73 | cellular response to exogenous dsRNA (GO:0071360) | 2.84265144 |
74 | negative thymic T cell selection (GO:0045060) | 2.82736467 |
75 | neutrophil mediated immunity (GO:0002446) | 2.82512117 |
76 | defense response to protozoan (GO:0042832) | 2.82198976 |
77 | T cell selection (GO:0045058) | 2.82141982 |
78 | positive thymic T cell selection (GO:0045059) | 2.82043665 |
79 | response to interferon-alpha (GO:0035455) | 2.81879181 |
80 | complement activation, alternative pathway (GO:0006957) | 2.81198071 |
81 | myeloid dendritic cell activation (GO:0001773) | 2.78865580 |
82 | regulation of antigen processing and presentation (GO:0002577) | 2.78534702 |
83 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.77336969 |
84 | regulation of type 2 immune response (GO:0002828) | 2.77279514 |
85 | granulocyte activation (GO:0036230) | 2.77095241 |
86 | mature B cell differentiation (GO:0002335) | 2.76647650 |
87 | negative T cell selection (GO:0043383) | 2.74128025 |
88 | phospholipid efflux (GO:0033700) | 2.74118170 |
89 | negative regulation of cell killing (GO:0031342) | 2.73221208 |
90 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.73221208 |
91 | positive regulation of humoral immune response (GO:0002922) | 2.72096741 |
92 | mast cell activation (GO:0045576) | 2.71870194 |
93 | response to muramyl dipeptide (GO:0032495) | 2.71322061 |
94 | myeloid cell activation involved in immune response (GO:0002275) | 2.70876391 |
95 | response to interferon-beta (GO:0035456) | 2.68148681 |
96 | T-helper 1 type immune response (GO:0042088) | 2.67138002 |
97 | tryptophan catabolic process (GO:0006569) | 2.65524777 |
98 | indole-containing compound catabolic process (GO:0042436) | 2.65524777 |
99 | indolalkylamine catabolic process (GO:0046218) | 2.65524777 |
100 | response to interleukin-15 (GO:0070672) | 2.64962650 |
101 | response to protozoan (GO:0001562) | 2.64808881 |
102 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.64478997 |
103 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.63661814 |
104 | germinal center formation (GO:0002467) | 2.62775318 |
105 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.62535351 |
106 | positive regulation of interferon-beta production (GO:0032728) | 2.62521533 |
107 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.62256296 |
108 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.61722762 |
109 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.59852602 |
110 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.56393996 |
111 | myeloid dendritic cell differentiation (GO:0043011) | 2.56075644 |
112 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.56049866 |
113 | mature B cell differentiation involved in immune response (GO:0002313) | 2.55730411 |
114 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.52587891 |
115 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.52289901 |
116 | detection of other organism (GO:0098543) | 2.50466242 |
117 | response to host immune response (GO:0052572) | 2.49659178 |
118 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.49659178 |
119 | cellular response to interferon-beta (GO:0035458) | 2.49626429 |
120 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.49277321 |
121 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.49065472 |
122 | cellular response to zinc ion (GO:0071294) | 2.48183748 |
123 | B cell mediated immunity (GO:0019724) | 2.47913977 |
124 | regulation of natural killer cell differentiation (GO:0032823) | 2.47388843 |
125 | interferon-gamma production (GO:0032609) | 2.47251115 |
126 | tryptophan metabolic process (GO:0006568) | 2.46922689 |
127 | aromatic amino acid family catabolic process (GO:0009074) | 2.45897138 |
128 | regulation of response to interferon-gamma (GO:0060330) | 2.45634022 |
129 | lymph node development (GO:0048535) | 2.45337207 |
130 | detection of molecule of bacterial origin (GO:0032490) | 2.44499390 |
131 | cellular response to interleukin-15 (GO:0071350) | 2.43675127 |
132 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.42104008 |
133 | negative regulation of interleukin-12 production (GO:0032695) | 2.42008134 |
134 | positive regulation of B cell mediated immunity (GO:0002714) | 2.38494998 |
135 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.38494998 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.27172194 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.62182064 |
3 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.21194801 |
4 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.03076958 |
5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.01660592 |
6 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.98600992 |
7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.87944276 |
8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.72536637 |
9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.36697404 |
10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.22485536 |
11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.22440452 |
12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.91210228 |
13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.86267376 |
14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.80248846 |
15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.79156799 |
16 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.65721783 |
17 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.58811003 |
18 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.49264488 |
19 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.45190501 |
20 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.44283635 |
21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.41955343 |
22 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.29741990 |
23 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.27160061 |
24 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.26696396 |
25 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.25460628 |
26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21469080 |
27 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.14875896 |
28 | MYB_26560356_Chip-Seq_TH2_Human | 2.03452597 |
29 | GATA1_22025678_ChIP-Seq_K562_Human | 2.01929902 |
30 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.97560804 |
31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.92572980 |
32 | * MAF_26560356_Chip-Seq_TH1_Human | 1.89946528 |
33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.86863206 |
34 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.84422567 |
35 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.83033302 |
36 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.82636902 |
37 | MYB_26560356_Chip-Seq_TH1_Human | 1.80570937 |
38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66176588 |
39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64662975 |
40 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.62106643 |
41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58070030 |
42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.57609627 |
43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.56426965 |
44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.56199333 |
45 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.52650463 |
46 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52128387 |
47 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.51922695 |
48 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.51218060 |
49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50882427 |
50 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.50340283 |
51 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.49755906 |
52 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.41432549 |
53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41014922 |
54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.40160038 |
55 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.39300909 |
56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.37762624 |
57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35969927 |
58 | MYC_22102868_ChIP-Seq_BL_Human | 1.35902192 |
59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.32889867 |
60 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32671552 |
61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.32491268 |
62 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.32315156 |
63 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.28279055 |
64 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.26442794 |
65 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.25762152 |
66 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25237633 |
67 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24132597 |
68 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23736678 |
69 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.23537172 |
70 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.20281310 |
71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.18832555 |
72 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16900937 |
73 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.07957810 |
74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06950483 |
75 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.06912133 |
76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06721844 |
77 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06544978 |
78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05872762 |
79 | MAF_26560356_Chip-Seq_TH2_Human | 1.05327054 |
80 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03081463 |
81 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.98401685 |
82 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95195418 |
83 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93763254 |
84 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93352041 |
85 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92765492 |
86 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.92381484 |
87 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92121843 |
88 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90693579 |
89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90608192 |
90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90273928 |
91 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.88839034 |
92 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.87681870 |
93 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.86297274 |
94 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.84302777 |
95 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83678420 |
96 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.83248884 |
97 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.81212075 |
98 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.80155925 |
99 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79333014 |
100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.77133643 |
101 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76571841 |
102 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.76404400 |
103 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76373776 |
104 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.75849414 |
105 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75573212 |
106 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73864202 |
107 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.73177096 |
108 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.72766480 |
109 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.71777549 |
110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71066671 |
111 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.70412186 |
112 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.69902336 |
113 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.69901926 |
114 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.67767452 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.14935255 |
2 | MP0009785_altered_susceptibility_to | 3.07429212 |
3 | MP0003436_decreased_susceptibility_to | 2.98787336 |
4 | MP0000685_abnormal_immune_system | 2.94528232 |
5 | * MP0001790_abnormal_immune_system | 2.90588531 |
6 | * MP0005387_immune_system_phenotype | 2.90588531 |
7 | MP0005671_abnormal_response_to | 2.85202699 |
8 | MP0003724_increased_susceptibility_to | 2.71315437 |
9 | * MP0001800_abnormal_humoral_immune | 2.70587013 |
10 | MP0002148_abnormal_hypersensitivity_rea | 2.64219975 |
11 | * MP0005025_abnormal_response_to | 2.62721651 |
12 | MP0005000_abnormal_immune_tolerance | 2.61907391 |
13 | MP0005360_urolithiasis | 2.53520042 |
14 | MP0002419_abnormal_innate_immunity | 2.52043428 |
15 | MP0002139_abnormal_hepatobiliary_system | 2.50126933 |
16 | * MP0002452_abnormal_antigen_presenting | 2.43916084 |
17 | * MP0002723_abnormal_immune_serum | 2.35355038 |
18 | MP0006082_CNS_inflammation | 2.18015894 |
19 | MP0005464_abnormal_platelet_physiology | 2.17813947 |
20 | * MP0001819_abnormal_immune_cell | 2.16959088 |
21 | * MP0002420_abnormal_adaptive_immunity | 2.16587960 |
22 | MP0002166_altered_tumor_susceptibility | 2.14186425 |
23 | MP0003191_abnormal_cellular_cholesterol | 2.07839751 |
24 | MP0003303_peritoneal_inflammation | 2.06297602 |
25 | MP0005365_abnormal_bile_salt | 1.99244021 |
26 | MP0005085_abnormal_gallbladder_physiolo | 1.95138486 |
27 | MP0009840_abnormal_foam_cell | 1.93396577 |
28 | MP0010155_abnormal_intestine_physiology | 1.87473211 |
29 | MP0002138_abnormal_hepatobiliary_system | 1.85384369 |
30 | MP0003300_gastrointestinal_ulcer | 1.84911108 |
31 | MP0003763_abnormal_thymus_physiology | 1.83311496 |
32 | MP0004510_myositis | 1.81097690 |
33 | MP0001853_heart_inflammation | 1.80117327 |
34 | MP0001845_abnormal_inflammatory_respons | 1.79114701 |
35 | MP0002405_respiratory_system_inflammati | 1.73278735 |
36 | * MP0000716_abnormal_immune_system | 1.73086343 |
37 | * MP0002398_abnormal_bone_marrow | 1.71613088 |
38 | MP0008875_abnormal_xenobiotic_pharmacok | 1.69862112 |
39 | MP0008469_abnormal_protein_level | 1.68556032 |
40 | MP0009764_decreased_sensitivity_to | 1.67419083 |
41 | * MP0004947_skin_inflammation | 1.66266499 |
42 | MP0002006_tumorigenesis | 1.66260168 |
43 | MP0005058_abnormal_lysosome_morphology | 1.63826664 |
44 | MP0001873_stomach_inflammation | 1.58764921 |
45 | MP0001533_abnormal_skeleton_physiology | 1.55026742 |
46 | MP0003252_abnormal_bile_duct | 1.52165643 |
47 | MP0000689_abnormal_spleen_morphology | 1.50200944 |
48 | MP0005451_abnormal_body_composition | 1.44231974 |
49 | MP0010329_abnormal_lipoprotein_level | 1.40010686 |
50 | * MP0002429_abnormal_blood_cell | 1.39721505 |
51 | * MP0002722_abnormal_immune_system | 1.37153936 |
52 | MP0009333_abnormal_splenocyte_physiolog | 1.36356591 |
53 | MP0008260_abnormal_autophagy | 1.34006153 |
54 | MP0003828_pulmonary_edema | 1.31461852 |
55 | MP0005397_hematopoietic_system_phenotyp | 1.30257236 |
56 | MP0001545_abnormal_hematopoietic_system | 1.30257236 |
57 | MP0000465_gastrointestinal_hemorrhage | 1.29763687 |
58 | MP0005310_abnormal_salivary_gland | 1.29338053 |
59 | MP0002396_abnormal_hematopoietic_system | 1.29010908 |
60 | MP0000609_abnormal_liver_physiology | 1.23288448 |
61 | MP0004883_abnormal_blood_vessel | 1.22680015 |
62 | MP0009278_abnormal_bone_marrow | 1.20068467 |
63 | MP0009763_increased_sensitivity_to | 1.17378203 |
64 | MP0003183_abnormal_peptide_metabolism | 1.17057467 |
65 | MP0001666_abnormal_nutrient_absorption | 1.16969018 |
66 | MP0003075_altered_response_to | 1.14846663 |
67 | MP0003866_abnormal_defecation | 1.14816830 |
68 | MP0008004_abnormal_stomach_pH | 1.10819077 |
69 | MP0004381_abnormal_hair_follicle | 1.09516893 |
70 | MP0005164_abnormal_response_to | 1.08865653 |
71 | MP0002277_abnormal_respiratory_mucosa | 1.07365065 |
72 | MP0002933_joint_inflammation | 1.06377178 |
73 | MP0004808_abnormal_hematopoietic_stem | 1.04940732 |
74 | MP0005083_abnormal_biliary_tract | 1.02648004 |
75 | MP0000343_altered_response_to | 1.01918357 |
76 | MP0005166_decreased_susceptibility_to | 1.01420822 |
77 | MP0002998_abnormal_bone_remodeling | 0.99064917 |
78 | MP0000858_altered_metastatic_potential | 0.96910812 |
79 | MP0004782_abnormal_surfactant_physiolog | 0.96260402 |
80 | MP0002254_reproductive_system_inflammat | 0.95444954 |
81 | MP0003806_abnormal_nucleotide_metabolis | 0.95356294 |
82 | MP0005319_abnormal_enzyme/_coenzyme | 0.94052490 |
83 | MP0003448_altered_tumor_morphology | 0.93594126 |
84 | MP0005174_abnormal_tail_pigmentation | 0.92197019 |
85 | MP0002132_abnormal_respiratory_system | 0.92029957 |
86 | MP0000703_abnormal_thymus_morphology | 0.91289711 |
87 | MP0003656_abnormal_erythrocyte_physiolo | 0.89508255 |
88 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89245474 |
89 | MP0003172_abnormal_lysosome_physiology | 0.87147565 |
90 | MP0009643_abnormal_urine_homeostasis | 0.86969646 |
91 | * MP0003045_fibrosis | 0.86316580 |
92 | MP0002118_abnormal_lipid_homeostasis | 0.85049963 |
93 | MP0003690_abnormal_glial_cell | 0.83725667 |
94 | MP0002136_abnormal_kidney_physiology | 0.80534710 |
95 | MP0003186_abnormal_redox_activity | 0.80452061 |
96 | MP0000249_abnormal_blood_vessel | 0.80445306 |
97 | MP0001851_eye_inflammation | 0.79481164 |
98 | MP0002332_abnormal_exercise_endurance | 0.79424662 |
99 | MP0000598_abnormal_liver_morphology | 0.78417783 |
100 | MP0001764_abnormal_homeostasis | 0.77560666 |
101 | MP0005332_abnormal_amino_acid | 0.77286508 |
102 | MP0003195_calcinosis | 0.77264122 |
103 | MP0002928_abnormal_bile_duct | 0.77173014 |
104 | MP0009765_abnormal_xenobiotic_induced | 0.76891399 |
105 | MP0005075_abnormal_melanosome_morpholog | 0.74588617 |
106 | MP0005390_skeleton_phenotype | 0.72981609 |
107 | MP0000490_abnormal_crypts_of | 0.71762654 |
108 | MP0000604_amyloidosis | 0.68457915 |
109 | MP0004019_abnormal_vitamin_homeostasis | 0.66807348 |
110 | MP0001663_abnormal_digestive_system | 0.65880038 |
111 | MP0003566_abnormal_cell_adhesion | 0.65393762 |
112 | MP0009642_abnormal_blood_homeostasis | 0.65104645 |
113 | MP0003091_abnormal_cell_migration | 0.65008628 |
114 | MP0003868_abnormal_feces_composition | 0.63591423 |
115 | MP0008874_decreased_physiological_sensi | 0.63443064 |
116 | MP0000015_abnormal_ear_pigmentation | 0.63000674 |
117 | MP0005167_abnormal_blood-brain_barrier | 0.62686482 |
118 | MP0003795_abnormal_bone_structure | 0.59433023 |
119 | MP0002693_abnormal_pancreas_physiology | 0.58169387 |
120 | MP0003453_abnormal_keratinocyte_physiol | 0.53372467 |
121 | MP0000371_diluted_coat_color | 0.53149940 |
122 | MP0006054_spinal_hemorrhage | 0.53062384 |
123 | MP0000569_abnormal_digit_pigmentation | 0.50754760 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 4.89438000 |
2 | Eczematoid dermatitis (HP:0000976) | 4.87654128 |
3 | Recurrent bacterial skin infections (HP:0005406) | 4.76273868 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.56855984 |
5 | Systemic lupus erythematosus (HP:0002725) | 4.25765184 |
6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.00795970 |
7 | Myositis (HP:0100614) | 3.73659818 |
8 | Recurrent fungal infections (HP:0002841) | 3.70341895 |
9 | Autoimmune thrombocytopenia (HP:0001973) | 3.67422303 |
10 | Recurrent skin infections (HP:0001581) | 3.60769221 |
11 | Recurrent viral infections (HP:0004429) | 3.55252695 |
12 | Chronic otitis media (HP:0000389) | 3.45218271 |
13 | Complement deficiency (HP:0004431) | 3.31691315 |
14 | Joint hemorrhage (HP:0005261) | 3.31408389 |
15 | Agammaglobulinemia (HP:0004432) | 3.27946792 |
16 | Vasculitis (HP:0002633) | 3.22417714 |
17 | Orchitis (HP:0100796) | 3.19537704 |
18 | Gingival bleeding (HP:0000225) | 3.19246259 |
19 | Vacuolated lymphocytes (HP:0001922) | 3.16536454 |
20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.14150401 |
21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.14150401 |
22 | Mediastinal lymphadenopathy (HP:0100721) | 3.14038633 |
23 | Abnormality of macrophages (HP:0004311) | 3.13391993 |
24 | Pustule (HP:0200039) | 3.13178573 |
25 | Meningitis (HP:0001287) | 3.12512337 |
26 | Spontaneous hematomas (HP:0007420) | 3.11861900 |
27 | Cellulitis (HP:0100658) | 3.10560910 |
28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.08755362 |
29 | Recurrent bronchitis (HP:0002837) | 3.04715384 |
30 | Glomerulonephritis (HP:0000099) | 3.03884974 |
31 | Prolonged partial thromboplastin time (HP:0003645) | 3.00816419 |
32 | IgM deficiency (HP:0002850) | 3.00032402 |
33 | Colitis (HP:0002583) | 2.95496570 |
34 | Inflammation of the large intestine (HP:0002037) | 2.87529876 |
35 | Retrobulbar optic neuritis (HP:0100654) | 2.86058276 |
36 | Optic neuritis (HP:0100653) | 2.86058276 |
37 | Periodontitis (HP:0000704) | 2.83193731 |
38 | Myocardial infarction (HP:0001658) | 2.81981410 |
39 | Abnormality of complement system (HP:0005339) | 2.81948474 |
40 | Abnormality of T cell number (HP:0011839) | 2.81781854 |
41 | Chest pain (HP:0100749) | 2.81683037 |
42 | Deep venous thrombosis (HP:0002625) | 2.81486108 |
43 | Epistaxis (HP:0000421) | 2.77570683 |
44 | Gingivitis (HP:0000230) | 2.77510684 |
45 | Anorexia (HP:0002039) | 2.75020052 |
46 | Gastrointestinal inflammation (HP:0004386) | 2.74297029 |
47 | T lymphocytopenia (HP:0005403) | 2.71299717 |
48 | Interstitial pulmonary disease (HP:0006530) | 2.64494511 |
49 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.64464523 |
50 | Nasal polyposis (HP:0100582) | 2.62092369 |
51 | Prolonged bleeding time (HP:0003010) | 2.62077346 |
52 | Obstructive lung disease (HP:0006536) | 2.61480231 |
53 | Chronic obstructive pulmonary disease (HP:0006510) | 2.61480231 |
54 | Hypergammaglobulinemia (HP:0010702) | 2.59457659 |
55 | Abnormality of T cells (HP:0002843) | 2.58395149 |
56 | Xanthomatosis (HP:0000991) | 2.58203550 |
57 | Arterial thrombosis (HP:0004420) | 2.57970235 |
58 | Abnormality of the nasal mucosa (HP:0000433) | 2.56720452 |
59 | Gangrene (HP:0100758) | 2.56456055 |
60 | Petechiae (HP:0000967) | 2.55444312 |
61 | Abnormality of T cell physiology (HP:0011840) | 2.50357366 |
62 | Panhypogammaglobulinemia (HP:0003139) | 2.50312760 |
63 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.47520241 |
64 | Hypochromic microcytic anemia (HP:0004840) | 2.47051824 |
65 | Stomatitis (HP:0010280) | 2.46362225 |
66 | Pulmonary infiltrates (HP:0002113) | 2.43419596 |
67 | Abnormality of glycolipid metabolism (HP:0010969) | 2.41376265 |
68 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.41376265 |
69 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.41376265 |
70 | Gastrointestinal infarctions (HP:0005244) | 2.41274562 |
71 | Episodic fever (HP:0001954) | 2.41216060 |
72 | Abnormality of the pleura (HP:0002103) | 2.41045380 |
73 | Pulmonary embolism (HP:0002204) | 2.40508953 |
74 | Abnormality of the common coagulation pathway (HP:0010990) | 2.40418805 |
75 | Thrombocytosis (HP:0001894) | 2.37855054 |
76 | Chronic diarrhea (HP:0002028) | 2.37275031 |
77 | Thyroiditis (HP:0100646) | 2.36714141 |
78 | Hypochromic anemia (HP:0001931) | 2.35992809 |
79 | IgG deficiency (HP:0004315) | 2.34507540 |
80 | Gastrointestinal stroma tumor (HP:0100723) | 2.34372875 |
81 | Osteomyelitis (HP:0002754) | 2.32914754 |
82 | Purpura (HP:0000979) | 2.32561647 |
83 | Leukocytosis (HP:0001974) | 2.31863122 |
84 | Urticaria (HP:0001025) | 2.31115953 |
85 | Mitral stenosis (HP:0001718) | 2.30651173 |
86 | Encephalitis (HP:0002383) | 2.29970296 |
87 | Microcytic anemia (HP:0001935) | 2.29712809 |
88 | Nephritis (HP:0000123) | 2.28712664 |
89 | Peritonitis (HP:0002586) | 2.27692431 |
90 | Lymphopenia (HP:0001888) | 2.26636369 |
91 | Hemoptysis (HP:0002105) | 2.25873867 |
92 | Abnormality of eosinophils (HP:0001879) | 2.25731321 |
93 | Menorrhagia (HP:0000132) | 2.25565758 |
94 | Hyperlipoproteinemia (HP:0010980) | 2.24898237 |
95 | Sepsis (HP:0100806) | 2.23038699 |
96 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.22484937 |
97 | Intrahepatic cholestasis (HP:0001406) | 2.22094178 |
98 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.20185211 |
99 | Joint swelling (HP:0001386) | 2.20045213 |
100 | Amyloidosis (HP:0011034) | 2.18895103 |
101 | Recurrent pneumonia (HP:0006532) | 2.18305822 |
102 | Keratoconjunctivitis sicca (HP:0001097) | 2.16127063 |
103 | Increased cerebral lipofuscin (HP:0011813) | 2.14449633 |
104 | Increased IgE level (HP:0003212) | 2.13443092 |
105 | Recurrent sinusitis (HP:0011108) | 2.11451935 |
106 | Dysostosis multiplex (HP:0000943) | 2.09605170 |
107 | Autoimmune hemolytic anemia (HP:0001890) | 2.08444527 |
108 | Abnormality of the peritoneum (HP:0002585) | 2.06820991 |
109 | Eosinophilia (HP:0001880) | 2.05176174 |
110 | Abnormality of B cell number (HP:0010975) | 2.04436886 |
111 | Premature loss of primary teeth (HP:0006323) | 2.03183808 |
112 | Hypoplasia of the thymus (HP:0000778) | 2.03095869 |
113 | Impaired platelet aggregation (HP:0003540) | 2.02794161 |
114 | Abnormal platelet function (HP:0011869) | 2.02794161 |
115 | Increased IgM level (HP:0003496) | 2.02744016 |
116 | Axonal loss (HP:0003447) | 2.01971695 |
117 | Keratoconjunctivitis (HP:0001096) | 2.01022858 |
118 | Severe combined immunodeficiency (HP:0004430) | 2.00760091 |
119 | Polyneuropathy (HP:0001271) | 1.99711734 |
120 | Granulocytopenia (HP:0001913) | 1.99625364 |
121 | Glomerulopathy (HP:0100820) | 1.99391480 |
122 | Skin ulcer (HP:0200042) | 1.98295801 |
123 | Keratitis (HP:0000491) | 1.98194293 |
124 | Abnormality of the pericardium (HP:0001697) | 1.94813254 |
125 | Vertigo (HP:0002321) | 1.94487635 |
126 | Thrombophlebitis (HP:0004418) | 1.94316656 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.06476974 |
2 | MAP3K14 | 3.34908592 |
3 | TYK2 | 3.04602488 |
4 | TXK | 3.01061234 |
5 | TAOK3 | 2.95739977 |
6 | ERN1 | 2.88448399 |
7 | IKBKE | 2.73408457 |
8 | TBK1 | 2.67441802 |
9 | IRAK4 | 2.53522943 |
10 | BLK | 2.48470013 |
11 | JAK3 | 2.43425412 |
12 | FGFR4 | 2.34039354 |
13 | KIT | 2.25731143 |
14 | JAK1 | 2.18509057 |
15 | IRAK3 | 2.12048551 |
16 | RIPK4 | 1.98577451 |
17 | ZAP70 | 1.94773709 |
18 | PRPF4B | 1.93748632 |
19 | BTK | 1.90305329 |
20 | IKBKB | 1.80574290 |
21 | TEC | 1.76155534 |
22 | FGR | 1.74597384 |
23 | MAP3K13 | 1.64333534 |
24 | TGFBR2 | 1.63380217 |
25 | SYK | 1.63377544 |
26 | EPHB1 | 1.60659302 |
27 | STK10 | 1.60453890 |
28 | CSK | 1.58618121 |
29 | CSF1R | 1.56739929 |
30 | FGFR3 | 1.40648943 |
31 | ITK | 1.40310315 |
32 | HCK | 1.35355679 |
33 | TAOK1 | 1.34978575 |
34 | GRK6 | 1.34504185 |
35 | NLK | 1.29184421 |
36 | CHUK | 1.26733236 |
37 | LCK | 1.26707772 |
38 | MAP3K11 | 1.21750834 |
39 | MST4 | 1.16140477 |
40 | PIM2 | 1.15048647 |
41 | LYN | 1.12323549 |
42 | ACVR1B | 1.09230676 |
43 | MAP3K10 | 1.06625309 |
44 | EPHA3 | 1.06427383 |
45 | PIM1 | 1.06135787 |
46 | TAOK2 | 1.05610618 |
47 | FES | 1.04348672 |
48 | TESK2 | 1.04248254 |
49 | JAK2 | 1.03334352 |
50 | SIK1 | 1.02225859 |
51 | MAP2K3 | 1.00635159 |
52 | NEK9 | 0.96345118 |
53 | KDR | 0.90368188 |
54 | CLK1 | 0.84665722 |
55 | SIK3 | 0.83835830 |
56 | FLT3 | 0.82898412 |
57 | MATK | 0.82303660 |
58 | PRKCQ | 0.82223071 |
59 | MST1R | 0.81656675 |
60 | LRRK2 | 0.81258281 |
61 | YES1 | 0.80672279 |
62 | MARK3 | 0.78066659 |
63 | SIK2 | 0.73804255 |
64 | NME2 | 0.73169151 |
65 | PIK3CG | 0.73042029 |
66 | TRPM7 | 0.70787059 |
67 | RPS6KA4 | 0.70140568 |
68 | KSR2 | 0.69962734 |
69 | MAPK11 | 0.69245877 |
70 | PTK6 | 0.69069031 |
71 | TIE1 | 0.67653127 |
72 | PTK2B | 0.67294441 |
73 | GRK7 | 0.66829855 |
74 | IRAK1 | 0.66335278 |
75 | CDC42BPA | 0.65413215 |
76 | MARK2 | 0.58382266 |
77 | TRIB3 | 0.58108912 |
78 | PRKCH | 0.57939546 |
79 | IRAK2 | 0.57766682 |
80 | FRK | 0.56540319 |
81 | STK4 | 0.55487554 |
82 | MAP3K5 | 0.55287037 |
83 | PDPK1 | 0.54970758 |
84 | CAMKK2 | 0.52916783 |
85 | HIPK2 | 0.52876079 |
86 | CAMK1D | 0.51673407 |
87 | TNK2 | 0.50733359 |
88 | MAP3K2 | 0.48940940 |
89 | ABL1 | 0.48249973 |
90 | PRKD2 | 0.47685860 |
91 | INSRR | 0.47276513 |
92 | NUAK1 | 0.46447830 |
93 | MAPK4 | 0.46383961 |
94 | PRKCD | 0.45906142 |
95 | MAP3K7 | 0.44940261 |
96 | PKN2 | 0.44612242 |
97 | ADRBK2 | 0.44536740 |
98 | MAP3K12 | 0.44002048 |
99 | MAP3K3 | 0.42178608 |
100 | EGFR | 0.41785014 |
101 | BMPR2 | 0.39850244 |
102 | RIPK1 | 0.39424331 |
103 | IGF1R | 0.39312277 |
104 | EEF2K | 0.38298018 |
105 | MAPKAPK2 | 0.38102890 |
106 | RPS6KA6 | 0.37302408 |
107 | SGK3 | 0.36690359 |
108 | BCKDK | 0.36599694 |
109 | GRK1 | 0.36437427 |
110 | CDK6 | 0.36215893 |
111 | PDK1 | 0.36100707 |
112 | PRKG2 | 0.35515615 |
113 | MAPK12 | 0.34914968 |
114 | MYLK | 0.34456756 |
115 | PRKAA2 | 0.34289634 |
116 | STK24 | 0.33388872 |
117 | MAP2K6 | 0.32741359 |
118 | MOS | 0.32360371 |
119 | MAPK7 | 0.31718255 |
120 | MAP3K1 | 0.30469445 |
121 | MAP2K2 | 0.28470221 |
122 | FYN | 0.28462771 |
123 | SGK2 | 0.28393899 |
124 | MAPK3 | 0.26286823 |
125 | RPS6KL1 | 0.26059859 |
126 | RPS6KC1 | 0.26059859 |
127 | SMG1 | 0.25934774 |
128 | CDK4 | 0.24950089 |
129 | RAF1 | 0.22347034 |
130 | BMX | 0.22001482 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.52993472 |
2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.81677950 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.57713142 |
4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.35748622 |
5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.33367749 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.29013470 |
7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.28303571 |
8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.27542772 |
9 | Measles_Homo sapiens_hsa05162 | 2.09810946 |
10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.05070188 |
11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.00161260 |
12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.98042498 |
13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.95446090 |
14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.92059216 |
15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.82456572 |
16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.81963916 |
17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.81174069 |
18 | Pertussis_Homo sapiens_hsa05133 | 1.74125752 |
19 | Allograft rejection_Homo sapiens_hsa05330 | 1.71253014 |
20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.67719347 |
21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.66182739 |
22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.48977061 |
23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.46972335 |
24 | Malaria_Homo sapiens_hsa05144 | 1.44144161 |
25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.42884008 |
26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.40968783 |
27 | Influenza A_Homo sapiens_hsa05164 | 1.40334113 |
28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39121629 |
29 | ABC transporters_Homo sapiens_hsa02010 | 1.37731251 |
30 | Tuberculosis_Homo sapiens_hsa05152 | 1.37642388 |
31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.34827218 |
32 | Legionellosis_Homo sapiens_hsa05134 | 1.34331070 |
33 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.33360088 |
34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32481957 |
35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.24943068 |
36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.21589694 |
37 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.20775856 |
38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15317690 |
39 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.14601615 |
40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.14551276 |
41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14039125 |
42 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.12942046 |
43 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.10137640 |
44 | Peroxisome_Homo sapiens_hsa04146 | 1.10112063 |
45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.07740999 |
46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07559737 |
47 | Hepatitis C_Homo sapiens_hsa05160 | 1.04656633 |
48 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.03563041 |
49 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.02985134 |
50 | Lysosome_Homo sapiens_hsa04142 | 0.97553126 |
51 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.96728854 |
52 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.94838209 |
53 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.94170775 |
54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93696881 |
55 | Asthma_Homo sapiens_hsa05310 | 0.91096964 |
56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.90262979 |
57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.89807188 |
58 | Apoptosis_Homo sapiens_hsa04210 | 0.89572269 |
59 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.89006703 |
60 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.88328821 |
61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.86984704 |
62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.85979986 |
63 | Shigellosis_Homo sapiens_hsa05131 | 0.84793021 |
64 | Hepatitis B_Homo sapiens_hsa05161 | 0.83988707 |
65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.83988383 |
66 | Retinol metabolism_Homo sapiens_hsa00830 | 0.80522292 |
67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79113760 |
68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.77505471 |
69 | Salmonella infection_Homo sapiens_hsa05132 | 0.76690194 |
70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.73486965 |
71 | Platelet activation_Homo sapiens_hsa04611 | 0.73445653 |
72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72899949 |
73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72692743 |
74 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.69354332 |
75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69004325 |
76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68654452 |
77 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68456899 |
78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67109847 |
79 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.66942910 |
80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.64611873 |
81 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.62528162 |
82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61339425 |
83 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.58111726 |
84 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.57897521 |
85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.57482774 |
86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56457858 |
87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56173640 |
88 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.55629173 |
89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54376741 |
90 | Endocytosis_Homo sapiens_hsa04144 | 0.53744306 |
91 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52685872 |
92 | Insulin resistance_Homo sapiens_hsa04931 | 0.51730998 |
93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51057029 |
94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50831829 |
95 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.50524613 |
96 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.50350380 |
97 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50071516 |
98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47284625 |
99 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46818372 |
100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46798978 |
101 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46265218 |
102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46172329 |
103 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46025845 |
104 | Phagosome_Homo sapiens_hsa04145 | 0.43731719 |
105 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42536534 |
106 | Bile secretion_Homo sapiens_hsa04976 | 0.41508256 |
107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41100305 |
108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40495460 |
109 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40127496 |
110 | Lysine degradation_Homo sapiens_hsa00310 | 0.40012405 |
111 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39040901 |
112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38216025 |
113 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.38021709 |
114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37131096 |
115 | Amoebiasis_Homo sapiens_hsa05146 | 0.35792546 |
116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35247167 |
117 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.35052935 |
118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34661625 |
119 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.33905248 |
120 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.33456556 |
121 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.33341021 |
122 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31071989 |
123 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.29546074 |
124 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.29239423 |
125 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28000051 |
126 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.27210832 |
127 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.26934728 |
128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.25739194 |
129 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.24256266 |
130 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.24154530 |
131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.23846660 |
132 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.23620160 |
133 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.23388577 |
134 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.20483817 |
135 | Endometrial cancer_Homo sapiens_hsa05213 | 0.18105430 |
136 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.18018034 |